Giuliani et al. demonstrated that the cell-to-cell contact between myeloma cells and BM MSCs by the integrin Very Late Antigen-4 (VLA-4) affect the RANKL/OPG ratio a favor of RANKL [36]. This evidence concerns the gene TNFSF11 and plasma cell myeloma.